National Healthcare Properties(NHP)
$14.82+0.31 (+2.14%)
NHP
National Healthcare Properties financials statements
$14.82
At close:+0.31 (+2.14%)
Want to see NHP full AI Analyst Report?
National Healthcare Properties (NHP) Ratios
3 Followers
National Healthcare Properties Ratios
NHP's free cash flow for Q3 2026 was $6.77M. For the 2026 fiscal year, NHP's free cash flow was decreased by $-8.96M and operating cash flow was $15.73M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 |
|---|---|---|---|
| Liquidity Ratios | |||
| Current Ratio | 0.24 | 0.22 | 0.28 |
| Quick Ratio | 0.24 | 0.22 | 0.28 |
| Cash Ratio | 0.10 | 0.05 | 0.11 |
| Solvency Ratio | 0.02 | -0.08 | 0.01 |
| Operating Cash Flow Ratio | 0.01 | -0.17 | 0.05 |
| Short-Term Operating Cash Flow Coverage | 0.01 | -0.22 | 0.06 |
| Net Current Asset Value | $ -968.06M | $ -1.15B | $ -1.13B |
| Leverage Ratios | |||
| Debt-to-Assets Ratio | 0.61 | 0.59 | 0.55 |
| Debt-to-Equity Ratio | 1.74 | 1.68 | 1.32 |
| Debt-to-Capital Ratio | 0.64 | 0.63 | 0.57 |
| Long-Term Debt-to-Capital Ratio | 0.46 | 0.53 | 0.47 |
| Financial Leverage Ratio | 2.85 | 2.84 | 2.40 |
| Debt Service Coverage Ratio | 0.14 | -0.09 | 0.18 |
| Interest Coverage Ratio | 0.05 | -1.78 | -0.07 |
| Debt to Market Cap | 5.03 | 3.36 | 3.45 |
| Interest Debt Per Share | 39.08 | 43.09 | 43.99 |
| Net Debt to EBITDA | 12.04 | -30.91 | 14.72 |
| Profitability Margins | |||
| Gross Profit Margin | 36.05% | 37.41% | 37.04% |
| EBIT Margin | 1.10% | -34.07% | -1.73% |
| EBITDA Margin | 23.96% | -10.31% | 22.22% |
| Operating Profit Margin | 0.96% | -34.92% | -1.37% |
| Pretax Profit Margin | -16.81% | -53.70% | -20.84% |
| Net Profit Margin | -16.83% | -53.62% | -20.90% |
| Continuous Operations Profit Margin | -16.85% | -53.78% | -20.92% |
| Net Income Per EBT | 100.17% | 99.84% | 100.31% |
| EBT Per EBIT | -1743.15% | 153.80% | 1521.25% |
| Return on Assets (ROA) | -3.37% | -9.75% | -3.37% |
| Return on Equity (ROE) | -9.60% | -27.71% | -8.09% |
| Return on Capital Employed (ROCE) | 0.29% | -8.33% | -0.27% |
| Return on Invested Capital (ROIC) | 0.20% | -6.69% | -0.23% |
| Return on Tangible Assets | -3.93% | -11.42% | -3.90% |
| Earnings Yield | -16.96% | -55.89% | -21.30% |
| Efficiency Ratios | |||
| Receivables Turnover | 11.14 | 12.33 | 13.14 |
| Payables Turnover | 4.93 | 2.47 | 4.50 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 46.40 | 47.30 | 44.85 |
| Asset Turnover | 0.20 | 0.18 | 0.16 |
| Working Capital Turnover Ratio | -0.86 | -1.07 | 0.00 |
| Cash Conversion Cycle | -41.22 | -118.04 | -53.26 |
| Days of Sales Outstanding | 32.78 | 29.60 | 27.78 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 74.00 | 147.64 | 81.04 |
| Operating Cycle | 32.78 | 29.60 | 27.78 |
| Cash Flow Ratios | |||
| Operating Cash Flow Per Share | 0.25 | -2.82 | 0.76 |
| Free Cash Flow Per Share | -0.77 | -3.60 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | 0.16 | -2.24 | 0.60 |
| Capital Expenditure Coverage Ratio | 0.24 | -3.64 | 0.97 |
| Operating Cash Flow Coverage Ratio | 0.01 | -0.07 | 0.02 |
| Operating Cash Flow to Sales Ratio | 0.02 | -0.23 | 0.06 |
| Free Cash Flow Yield | -6.41% | -29.98% | -0.23% |
| Valuation Ratios | |||
| Price-to-Earnings (P/E) Ratio | -4.78 | -1.67 | -4.69 |
| Price-to-Sales (P/S) Ratio | 0.99 | 0.96 | 0.98 |
| Price-to-Book (P/B) Ratio | 0.57 | 0.50 | 0.38 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -15.60 | -3.34 | -439.02 |
| Price-to-Operating Cash Flow Ratio | 48.88 | -4.25 | 15.69 |
| Price-to-Earnings Growth (PEG) Ratio | 0.07 | -0.01 | 0.60 |
| Enterprise Value Multiple | 14.56 | -40.21 | 19.14 |
| Enterprise Value | 1.19B | 1.47B | 1.47B |
| EV to EBITDA | 14.56 | -40.21 | 19.14 |
| EV to Sales | 3.49 | 4.15 | 4.25 |
| EV to Free Cash Flow | -54.83 | -14.42 | -1902.99 |
| EV to Operating Cash Flow | 171.75 | -18.38 | 68.03 |
| Tangible Book Value Per Share | 12.64 | 24.40 | 31.85 |
| Shareholders’ Equity Per Share | 21.19 | 24.20 | 31.62 |
| Tax and Other Ratios | |||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 12.09 | 12.51 | 12.23 |
| Net Income Per Share | -2.04 | -6.71 | -2.56 |
| Tax Burden | 1.00 | 1.00 | 1.00 |
| Interest Burden | -15.31 | 1.58 | 12.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.07 | 0.06 | 0.05 |
| Stock-Based Compensation to Revenue | 0.01 | 0.00 | 0.00 |
| Income Quality | -0.12 | 0.42 | -0.30 |
Currency in USD
